Protoporphyria, Erythropoietic

Also known as: Erythropoietic Protoporphyria / Protoporphyrias, Erythropoietic / Porphyria non-acute / Congenital erythropoietic porphyria / EPP

DrugDrug NameDrug Description
DB04931AfamelanotideAn injectable subcutaneous implant used to mitigate phototoxicity secondary to erythropoietic protoporphyria (EPP).
DrugDrug NamePhaseStatusCount
DB04931Afamelanotide2Completed1
DB00375Colestipol2 / 3Completed1
DB04931Afamelanotide3Completed3
DB09485Cysteine3Completed1
DB09485CysteineNot AvailableCompleted1
DB13257Ferrous sulfate anhydrousNot AvailableCompleted1